Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Leiomyoma × Naproxen × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pain 2 Colorectal Neoplasms, Hereditary Nonpolyposis 2 Uterine Diseases 1 Prostatic Neoplasms 1 Pleural Effusion, Malignant 1 Pleural Effusion 1 Lung Neoplasms 1 Leiomyoma 1 Inflammation 1 Hyperuricemia 1 Gout 1 Dysmenorrhea 1 Colorectal Neoplasms 1 Cardiovascular Diseases 1 Breast Neoplasms 1 Arthritis 1

Interventions

ulipristal acetate 18 Uterine Myomectomy 17 telapristone acetate 16 vilaprisan 11 Uterine Artery Embolization 10 relugolix 9 Leuprolide 9 asoprisnil 7 Mifepristone 7 ulipristal 6 estradiol, norethindrone drug combination 6 elagolix 6 Tranexamic Acid 6 Hysterectomy 6 Estradiol 6 Bupivacaine 6 Norethindrone Acetate 5 linzagolix 4 epigallocatechin gallate 4 Sodium Chloride 4 Saline Solution 4 Letrozole 4 Vitamin B 6 3 Radiofrequency Ablation 3 Misoprostol 3 Gonadotropin-Releasing Hormone 3 Embolization, Therapeutic 3 cetrorelix 2 Vitamin D 2 Tea 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04145518 2025-12-12

MCUP

Endeavor Health

Phase 4 Completed

Dysmenorrhea, Leiomyoma, Pain, Uterine Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡